The North America Tumor Ablation Market would witness market growth of 9.4% CAGR during the forecast period (2019-2025). Tumor ablation treatment is an excellent option over many other conventional treatment methods owing to its minimal invasiveness. For patients who are unable to undergo surgery due to medical reasons, it has been considered the best choice. It is highly effective and safe in treating patients with four or few tumors confined to a small region, chemotherapy is considered more effective for larger and greater numbers of tumors. One of the facilitating factors of the revolutionary treatment has been the high success rate of tumor ablation, which also makes it one of the most favored tumor therapies where other therapies might not be effective for multiple reasons. The procedure of tumor ablation has been used to treat different types of cancer such as colorectal cancer, lung cancer, liver cancer, prostate cancer, etc.
Microwave tumor ablation technology has been the fastest-growing category of ablation technology currently used to manage various cancers (like lung, liver, and kidney). Growth in the microwave ablation segment can be attributed to increased private funding for new microwave ablation product development, drastic efficiency over other ablation technologies, and increased adoption by health care professionals of the microwave tumor ablation procedure to treat different cancers.
The percutaneous ablation techniques are well known in cancer treatment for both cure and local regulation of many forms of tumors. Tumor tissue cryoablation leads to cell destruction by freezing. Cryoablation leads to tumor cell death by osmosis and necrosis, in comparison to heat-based ablative modalities. It is observed that the intracellular contents of cancer cells remain intact with necrosis allowing an immune-specific reaction to being induced by the immune system.
Based on Treatment, the market is segmented into Surgical Ablation, Laparoscopic Ablation and Percutaneous Ablation. Based on Technology, the market is segmented into Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation and Other Technology. Based on Application, the market is segmented into Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Cancer. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: Tumor Ablation Market in North America is expected to register a CAGR of 9.4% during the forecast period (2019-2025)
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Johnson and Johnson (Ethicon, Inc.), Boston Scientific Corporation, Misonix, Inc., EDAP TMS S.A., Theraclion SA, AngioDynamics, Inc., Mermaid Medical A/S, HealthTronics, Inc. (Altaris Capital Partners, LLC), and SonaCare Medical, LLC.
Market Segmentation:
By Treatment
By Technology
By Application
By Country
Companies Profiled
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 